Coe Capital Management, LLC - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 388 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.46 and the average weighting 0.3%.

Quarter-by-quarter ownership
Coe Capital Management, LLC ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2019$604,000
-9.6%
6,066
+3.7%
0.67%
-9.5%
Q2 2019$668,000
-9.7%
5,848
-0.7%
0.74%
-14.1%
Q1 2019$740,000
-8.4%
5,889
-1.1%
0.86%
-13.3%
Q4 2018$808,000
-57.4%
5,955
-13.8%
0.99%
-47.0%
Q3 2018$1,895,000
+33.3%
6,905
+0.6%
1.87%
+18.3%
Q2 2018$1,422,000
+25.4%
6,8650.0%1.58%
+28.6%
Q1 2018$1,134,000
+22.6%
6,865
+1.6%
1.23%
+25.8%
Q4 2017$925,000
-2.4%
6,755
-3.0%
0.98%
-0.8%
Q3 2017$948,0006,9650.98%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Knott David M Jr 115,000$6,8912.63%
VILLERE ST DENIS J & CO LLC 438,161$26,254,6072.24%
RICE HALL JAMES & ASSOCIATES, LLC 282,961$16,955,0231.08%
Chicago Capital, LLC 360,345$21,591,8841.01%
CARDINAL CAPITAL MANAGEMENT LLC /CT 206,399$12,367,4280.53%
Smith, Graham & Co., Investment Advisors, LP 61,849$3,705,9920.46%
Stephens Investment Management Group LLC 467,564$28,016,4350.46%
Jackson Creek Investment Advisors LLC 13,657$8180.34%
Court Place Advisors, LLC 15,133$906,7690.32%
Ziegler Capital Management, LLC 123,158$7,379,1760.30%
View complete list of LIGAND PHARMACEUTICALS INC shareholders